Breast Cancer – TerSera TER-ZLDX-0101

Breast Cancer Research Study

Consider a research study focused on reducing injections.

Profound Research is enrolling a Breast Cancer study that is assessing Zoladex® (goserelin implant) to see whether a longer-acting formulation given once every 3 months may reduce how often the medicine needs to be given.

To be eligible to participate, you must:

  • Be a female 18-55 years of age with a BMI of 18-35
  • Be premenopausal
  • Have been diagnosed with advanced or metastatic HR+/HER2- breast cancer
  • Be new to ovarian suppression treatment or have been taking it for 6 months or less. (This includes Zoladex®, Lupron®, or Trelstar®)

Additional criteria apply.

Qualified participants will receive:

  • Study-related care and Zoladex® at no cost
  • Financial compensation for time and travel expenses

Fill out the contact form and we’ll be in touch soon with more information. 

Trial Interest Form

Locations

MHP MedOnc Royal Oak - Oakland Medical Group

3577 W. 13 Mile Rd
Suites 310 & 404
Royal Oak, Michigan